Archive - March 2022
Novo Nordisk Receives FDA Approval of Higher-Dose Ozempic 2 mg Providing Increased Glycemic Control for Adults with Type 2 Diabetes
Is The BA.2 Variant More Severe For Children?
Janssen COVID-19 Vaccine Records More Deaths Than Other Vaccines
What’s next in adoptive cell therapy
CHMP recommends marketing authorisation for AZ’s Evusheld in the EU
Novartis’ Kesimpta trial evaluates treatment of COVID-19 in MS patients
Stalicla completes phase 1b trials into precision medicine for autism spectrum disorder
Jazz Pharmaceuticals reveals new manufacturing facility for cannabis-based medicines